Maple Rock Capital Partners Inc. Has $52.01 Million Holdings in Bausch Health Cos Inc. $BHC

Maple Rock Capital Partners Inc. increased its holdings in shares of Bausch Health Cos Inc. (NYSE:BHC) by 14.9% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 7,808,487 shares of the company’s stock after purchasing an additional 1,010,987 shares during the period. Bausch Health Cos makes up approximately 2.5% of Maple Rock Capital Partners Inc.’s holdings, making the stock its 16th largest position. Maple Rock Capital Partners Inc. owned 2.11% of Bausch Health Cos worth $52,005,000 at the end of the most recent quarter.

Other institutional investors also recently added to or reduced their stakes in the company. Caitong International Asset Management Co. Ltd acquired a new stake in shares of Bausch Health Cos in the first quarter worth $27,000. Russell Investments Group Ltd. grew its position in Bausch Health Cos by 65.9% in the 2nd quarter. Russell Investments Group Ltd. now owns 7,819 shares of the company’s stock worth $51,000 after purchasing an additional 3,106 shares during the last quarter. Alpha Wealth Funds LLC acquired a new stake in Bausch Health Cos in the 2nd quarter worth $65,000. Stratos Wealth Advisors LLC bought a new position in shares of Bausch Health Cos during the 2nd quarter worth about $67,000. Finally, Dynamic Technology Lab Private Ltd acquired a new position in shares of Bausch Health Cos during the first quarter valued at about $68,000. 78.65% of the stock is owned by institutional investors.

Analysts Set New Price Targets

BHC has been the topic of several research reports. Weiss Ratings restated a “hold (c-)” rating on shares of Bausch Health Cos in a research note on Monday. Barclays started coverage on shares of Bausch Health Cos in a research note on Monday. They set an “equal weight” rating and a $8.00 price target on the stock. Finally, Wall Street Zen upgraded shares of Bausch Health Cos from a “buy” rating to a “strong-buy” rating in a research note on Saturday, November 1st. Four equities research analysts have rated the stock with a Hold rating, According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $8.67.

Bausch Health Cos Stock Up 2.8%

Shares of NYSE:BHC opened at $7.01 on Friday. The company’s fifty day moving average is $6.46 and its 200-day moving average is $6.45. The company has a debt-to-equity ratio of 57.48, a quick ratio of 0.97 and a current ratio of 1.30. Bausch Health Cos Inc. has a 52 week low of $4.25 and a 52 week high of $8.69. The company has a market capitalization of $2.60 billion, a PE ratio of 7.23 and a beta of 0.41.

About Bausch Health Cos

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.